MedTrace Logo

Results in Real Clinical Practice of Treatment of Moderate-severe Atopic Dermatitis

NCT05078294 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-11-17

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy results in terms of percentage improvement of the Eczema Area and Severity Index (EASI) as well as on the scale Patient Global Assessment (PGA) throughout the follow-up of patients undergoing subjected to systemic and/or biological treatments in conditions of usual clinical practice. Likewise, collect safety data, recording adverse events related to medication.

Conditions

  • Dermatitis, Atopic

Sponsors & Collaborators

  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

    lead OTHER

Principal Investigators

  • José Juan Pereyra Rodríguez · Hospitales Universitarios Virgen del Rocío

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2024-06-01
Completion
2024-11-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05078294 on ClinicalTrials.gov